13620-82-1

Basic information

• Product Name: Allylpyrocatechol -3,4-diacetate
• Synonyms: Allylpyrocatechol -3,4-diacetate;4-Allyl-1,2-diacetoxybenzene;4-Allylpyrocatechol diacetate;1,2-Diacetoxy-4-allylbenzene;4-(2-Propenyl)-1,2-benzenediol 1,2-diacetate;4-Allylcatechol diacetate
• CAS NO: 13620-82-1
• Molecular Formula: C₁₃H₁₄O₄
• Molecular Weight: 264.23078
• Mol File: 13620-82-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 310.4°Cat760mmHg
• Flash Point: 148℃
• Appearance: /
• Density: 1.120
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Allylpyrocatechol -3,4-diacetate(CAS DataBase Reference)
• NIST Chemistry Reference: Allylpyrocatechol -3,4-diacetate(13620-82-1)
• EPA Substance Registry System: Allylpyrocatechol -3,4-diacetate(13620-82-1)

Safety Data

• Hazardous Substances Data: 13620-82-1(Hazardous Substances Data)

Usage

General Description

Allylpyrocatechol-3,4-diacetate is a chemical compound derived from pyrocatechol, a type of phenol. It is formed through the acetylation of allylpyrocatechol, resulting in the formation of acetate esters at the 3 and 4 positions on the pyrocatechol ring. Allylpyrocatechol -3,4-diacetate is often used in the synthesis of pharmaceuticals, dyes, and fragrances, as well as in organic reactions to introduce aromatic functionalities. Its unique chemical structure and properties make it a valuable precursor in the production of various compounds with applications in different industries. Additionally, allylpyrocatechol-3,4-diacetate may also have potential biological activities and pharmacological properties, although further research is needed to fully understand its potential uses in medicine and other fields.

Upstream product

• 1125-74-2 3-(2-propenyl)-1,2-benzenediol 
• 75-36-5 acetyl chloride 
• 97-53-0 4-allylguaiacol 
• 94-59-7 1-allyl-3,4-methylenedioxybenzene 
• 1126-20-1 2-allyloxyphenol 
• 93-15-2 1,2-dimethoxy-4-(2-propenyl)benzene 
• 1126-61-0 4-allylpyrocatechol 
• 108-24-7 acetic anhydride 

Downstream Products

• 46118-02-9 3-(3',4'-dihydroxyphenyl)-1-propanol 
• 147000-27-9 4-[3-(acetyloxy)propyl]-1,2-phenylene diacetate 
• 89266-70-6 4-propyl-1,2-phenyl diacetate 
• 1579274-04-6 4-(2,3-dihydroxypropyl)-1,2-phenylene diacetate 
• 141632-15-7 (E)-3-(3,4-dihydroxyphenyl)acrylaldehyde 
• 402761-80-2 (E)-4-(3-oxoprop-1-en-1-yl)-1,2-phenylene diacetate 

Relevant articles and documents

DDQ-mediated oxidation of allylarenes: Expedient access to cinnamaldehyde-containing phenylpropanoids

Phenylpropanoid natural products containing a cinnamaldehyde motif were easily synthesized from allylarenes mediated by 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) oxidation. Representative examples described herein are five types of 4-hydroxycinnamaldehyde derivatives from monolignols biosynthesis, Boropinal C, and 7-methoxywutaifuranal from plant extracts. Especially, simple synthesis of 7-methoxywutaifuranal was exploited through selective mono-oxidation and subsequent isomerization-ring-closing-metathesis strategy.

SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA

The present invention relates to compounds of general formula 1 for the treatment of bronchial asthma by inhibition of IL-4 or IL-5 pathway inhibition. The present invention also relates to the use of compound of general formula 1 for the treatment of bronchial by inhibition of IL-4 or IL-5 pathway. The present invention also relates to the method of treating asthma by inhibition of IL-4 or IL-5 pathway by administration of compound or said composition through oral, intranasal, route or by inhalation to a mammal in need thereof. Compound of general formula 1 may be used for reducing perivascular and peribronchial inflammation.

INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO)

The present invention relates to compounds of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention further relates to a method of treating malignancy by inhibition of PI3-Akt pathway and or induction of NO by administration of compound or said composition to a mammal in need thereof.